Ketamine for Pain: A New Way to Manage Acute Pain (Shi et al., 2024)
Introduction: In January 2024, Shi and colleagues published a study in the Journal of the College of Physicians and Surgeons […]
Problem
Mechanisms and Clinical Applications of Ketamine Variants in Depression (Kawczak et al., 2024)
Introduction: Kawczak et al.’s 2024 review in Biomedicines explores ketamine, esketamine, and arketamine’s mechanisms of action and their applications in
Ketamine and Its Variants: Unlocking New Hope for Depression (Kawczak et al., 2024)
Introduction: In October 2024, Kawczak and colleagues published an in-depth review in Biomedicines discussing ketamine and its variants (esketamine and
Ketamine Pilot Study for Late-Life Depression: Early Insights (Lenze, ClinicalTrials.gov, 2020)
Introduction: Dr. Eric Lenze’s 2020 pilot study investigates ketamine’s safety and efficacy in older adults with treatment-resistant depression (TRD). This
Exploring Ketamine for Older Adults: A Groundbreaking Pilot Study (Lenze, ClinicalTrials.gov, 2020)
Introduction: In 2020, Dr. Eric Lenze and his team launched a pilot study to explore how ketamine might help older
Esketamine: A Fast-Acting Treatment for Depression, Explained (Hough, FDA, 2019)
Introduction: In 2019, the FDA approved esketamine, a nasal spray developed for people with treatment-resistant depression (TRD). This report by
Esketamine: A New Hope for Treatment-Resistant Depression (FDA Advisory Committees, 2019)
Introduction: The FDA reviewed a new treatment called esketamine, a nasal spray developed for people with treatment-resistant depression (TRD). TRD
Ketamine and Esketamine Trials for TRD: A Clinical Update (Duke Scholars, January 2023)
Introduction: Ketamine and esketamine are increasingly investigated for their potential in managing TRD. This systematic review examines clinical trials registered
Ketamine and Esketamine for Depression: Promising Hope for Tough Cases (Duke Scholars, January 2023)
Introduction: Ketamine and esketamine have been explored in medical research for treating treatment-resistant depression (TRD), a severe form of depression
Ketamine’s Role in Depression: How Gender Influences Effects and Risks – Insights from Wright & Kabbaj’s 2018 Study
Introduction: In their 2018 study, researchers Wright and Kabbaj explored how ketamine’s antidepressant effects and potential for misuse differ between